Inimmune Advances Phase 2 Trial of INI-2004, Aiming to Transform Allergic Rhinitis Treatment Inimmune has completed enrollment in its Phase 2 trial for INI-2004, an innovative treatment for allergic rhinitis, expected to yield crucial data soon.

Inimmune Advances Phase 2 Trial of INI-2004, Aiming to Transform Allergic Rhinitis Treatment #United_States #Missoula #Allergic_Rhinitis #INI-2004 #Inimmune_Corporation